Engineered nanoparticles as precise drug delivery systems.
about
Design and Application of Antimicrobial Peptide ConjugatesCurrent and future trials of targeted therapies in cutaneous melanomaPhotodynamic therapy of a 2-methoxyestradiol tumor-targeting drug delivery system mediated by Asn-Gly-Arg in breast cancer.Nanoparticle penetration and transport in living pumpkin plants: in situ subcellular identificationAdvanced Analgesic Drug Delivery and Nanobiotechnology.Preparation and sustained-release property of triblock copolymer/calcium phosphate nanocomposite as nanocarrier for hydrophobic drugMolecular dynamics study of the behavior of selected nanoscale building blocks in a gel-phase lipid bilayer.Encapsulation of plasmid DNA in calcium phosphate nanoparticles: stem cell uptake and gene transfer efficiencyNovel strategies for managing pancreatic cancer.Circumventing tumor resistance to chemotherapy by nanotechnologyCurrent and future clinical applications for optical imaging of cancer: from intraoperative surgical guidance to cancer screeningEvaluation of nanoparticle uptake in co-culture cancer models.Antitumor effect of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles on mice bearing breast cancer: a systemic toxicity assayTargeted delivery of nanomedicines.Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering.Intrabody strategies for the treatment of human papillomavirus-associated disease.Use of degradable and nondegradable nanomaterials for controlled release.Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs.Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells.Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response.Strategies toward the improved oral delivery of insulin nanoparticles via gastrointestinal uptake and translocation.Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas.Polymer-drug interactions in tyrosine-derived triblock copolymer nanospheres: a computational modeling approach.DNA nanotubes as combinatorial vehicles for cellular delivery.Current achievements of nanoparticle applications in developing optical sensing and imaging techniques.Antidiabetic activity of zinc oxide and silver nanoparticles on streptozotocin-induced diabetic rats.Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail.Active food packaging evolution: transformation from micro- to nanotechnology.Calcium phosphate-based composite nanoparticles in bioimaging and therapeutic delivery applications.Has nanotechnology led to improved therapeutic outcomes?Thiomers and thiomer-based nanoparticles in protein and DNA drug delivery.Nanoparticle-based therapy for respiratory diseases.Applications and perspectives of boron-enriched nanocomposites in cancer therapy.Colloidal drug delivery system: amplify the ocular delivery.Inorganic nanomaterials for bioimaging, targeted drug delivery and therapeutics.Nanotheragnostic applications for ischemic and hemorrhagic strokes: improved delivery for a better prognosis.Designing a better theranostic nanocarrier for cancer applications.Nanoscaled boron-containing delivery systems and therapeutic agents for cancer treatment.Alginate gel particles-A review of production techniques and physical properties.Promising Approaches to Optimize the Biological Properties of the Antimicrobial Peptide Esculentin-1a(1-21)NH2: Amino Acids Substitution and Conjugation to Nanoparticles
P2860
Q26749068-3E34863A-D2AC-4CA9-8D91-64E05FFFC5B9Q27022355-02A6A720-0A36-4D22-BADA-0A9A07499912Q30454988-21B126B5-ED91-4872-A488-853AEBD56E93Q33434185-7E127133-ACED-4F15-AC95-0E735AF795CBQ33845298-55B4B268-3F12-4164-87FB-456118D0989EQ33947568-060B287B-FF48-4185-B511-EAF7B08384BEQ34077562-9F3AF13C-2FFE-48D6-84EB-A24AC60B8C58Q34121750-9FE8FB90-4240-4F24-A6A9-FF6E7A9DC21EQ34405057-2B399E05-B42A-4602-BF76-4AE0856CF89AQ34618357-ED62AC6A-4AF4-495A-A25B-CA92878D0C4AQ34700347-0B6890F9-FF34-4A0B-B2C7-21C9F0977359Q34905683-CE9E4289-AF10-4079-9858-2F3AC2DEA1E5Q35652859-FF693F71-6CDE-4A2E-8FFD-F971ED69AB51Q35915020-DBDD8D55-8032-4D6E-BCFA-9326867E0FD1Q36590092-6451C01B-FEDE-4C46-BC74-B1396F8B6A01Q36810292-AD58B815-783C-44AD-B967-DE965B540B20Q36917951-813EEA71-C01D-4290-81DE-59021798BCCBQ36985913-D8FF0B12-BF65-426B-BD46-9A8BE4263224Q37074644-B4C7E486-F740-445C-86A6-874DE43B3AE8Q37167802-35888F19-27C9-4FE8-9208-78D285950677Q37210480-255734F8-F858-4CFF-A8B9-CA38F4E20065Q37236431-B28C0A40-1720-43DF-8EE2-68C3641692B8Q37380059-46B6E401-CC2D-4237-94C9-FE4B7D95EDF0Q37383894-A3371CFF-1C07-403F-892C-535E8569EDBCQ37610369-4958980E-B500-4584-A3FF-C8E889116BB7Q37645135-F2E6D7E2-BDF1-44C3-B82B-D91027747490Q37745182-D5CAD5A2-3556-40EE-B5A5-3C2C4215FC53Q37798206-6ED41B8A-7EAA-451E-87C7-975BE454FD45Q37941545-127EAAC3-406C-4A8D-9B04-9ADDDF112D27Q37970730-90674A10-89FC-4C06-BAAA-D3C189C05541Q38019050-21619970-280F-4578-B6AE-147E52C2C2ADQ38086501-2458C21B-D296-4DF6-9986-A12434ECD6D3Q38101624-24A52CED-CA67-49BD-A742-2C0EDB3B14D0Q38217270-5A587693-CD14-49D5-9252-2808E3AAC9B9Q38222448-A902450E-4AE3-45C2-9495-98421DA19C54Q38267991-9DA19989-FC0D-4B47-8A8A-8487E3ABC587Q38270094-6EC191B9-19B1-49FC-A47D-EE77C3ADF824Q38451910-CE40DCF5-3CD1-475E-95F0-A9FC79E26614Q38481648-7C5C0286-B428-4B84-BC24-C3E29FFC049EQ38685826-3A81A57E-4C2B-4637-BD21-C796B22A35A4
P2860
Engineered nanoparticles as precise drug delivery systems.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Engineered nanoparticles as precise drug delivery systems.
@ast
Engineered nanoparticles as precise drug delivery systems.
@en
type
label
Engineered nanoparticles as precise drug delivery systems.
@ast
Engineered nanoparticles as precise drug delivery systems.
@en
prefLabel
Engineered nanoparticles as precise drug delivery systems.
@ast
Engineered nanoparticles as precise drug delivery systems.
@en
P356
P1476
Engineered nanoparticles as precise drug delivery systems
@en
P2093
P2860
P304
P356
10.1002/JCB.20796
P50
P577
2006-04-01T00:00:00Z